The Beauty Health Company (SKIN)
NASDAQ: SKIN · IEX Real-Time Price · USD
1.960
+0.120 (6.52%)
At close: Jul 2, 2024, 4:00 PM
1.979
+0.019 (0.97%)
After-hours: Jul 2, 2024, 5:47 PM EDT
The Beauty Health Company Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for SKIN stock have an average target of 4.29, with a low estimate of 1.50 and a high estimate of 10. The average target predicts an increase of 118.88% from the current stock price of 1.96.
Analyst Consensus: Hold
* Price targets were last updated on May 13, 2024.
Analyst Ratings
The average analyst rating for SKIN stock from 11 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 7 | 7 | 7 | 7 | 6 | 6 |
| Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 12 | 12 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DA Davidson | DA Davidson | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +155.10% | May 13, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +53.06% | May 13, 2024 |
| Piper Sandler | Piper Sandler | Sell Maintains $3 → $2.5 | Sell | Maintains | $3 → $2.5 | +27.55% | May 10, 2024 |
| DA Davidson | DA Davidson | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +155.10% | Mar 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +104.08% | Mar 14, 2024 |
Financial Forecast
Revenue This Year
406.27M
from 397.99M
Increased by 2.08%
Revenue Next Year
445.95M
from 406.27M
Increased by 9.77%
EPS This Year
-0.01
from -0.76
EPS Next Year
0.04
from -0.01
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 430.1M | 473.2M | 517.7M | 528.5M | 568.9M |
| Avg | 406.3M | 446.0M | 491.3M | 513.4M | 552.6M |
| Low | 376.5M | 410.7M | 458.4M | 493.2M | 531.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.1% | 16.5% | 16.1% | 7.6% | 10.8% |
| Avg | 2.1% | 9.8% | 10.2% | 4.5% | 7.6% |
| Low | -5.4% | 1.1% | 2.8% | 0.4% | 3.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.21 | 0.32 | 0.42 |
| Avg | -0.01 | 0.04 | 0.16 |
| Low | -0.21 | -0.21 | 0.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 958.8% |
| Avg | - | - | 302.9% |
| Low | - | - | -75.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.